Skip to content
EntityQ1003185· pop 7· linked from 597 articles

fosfestrol

Sign in to save

Also known as diethylstilbestryl diphosphate, Diethylstilbestrol bisphosphate, diethylstilbestrol diphosphate, Difostilben

Fosfestrol, sold under the brand name Honvan and also known as diethylstilbestrol diphosphate (DESDP), is an estrogen medication which is used in the treatment of prostate cancer in men. It is given by slow intravenous infusion once per day to once per week or by mouth once per day.

Research

209 papers

via PubMed

~6 min read

Encyclopedic overview

15 sections
Contents
  • Medical uses
  • Available forms
  • Side effects
  • Pharmacology
  • Pharmacodynamics
  • Pharmacokinetics
  • Chemistry
  • History
  • Society and culture
  • Generic names
  • Brand names
  • Availability
  • See also
  • References
  • Further reading

Fosfestrol, sold under the brand name Honvan and also known as diethylstilbestrol diphosphate (DESDP), is an estrogen medication which is used in the treatment of prostate cancer in men. It is given by slow intravenous infusion once per day to once per week or by mouth once per day.

Side effects of fosfestrol include nausea and vomiting, cardiovascular complications, blood clots, edema, and genital skin reactions, among others. Fosfestrol is an estrogen, and hence is an agonist of the estrogen receptor, the biological target of estrogens like estradiol. It acts as a prodrug of diethylstilbestrol.

Excerpted from Wikipedia’s “fosfestrol” article, available under the CC BY-SA 4.0 licence.

Available in 7 languages

via Wikidata sitelinks · CC0